An Editor at Large: It’s bad enough that the President got serious about tariffs, says columnist Gerard Baker, but how in the world did he end up embracing regime change? Photo: Matt Rourke/Associated ...

Building Equity Management doesn’t appear to be ready to tip its hand, but its latest acquisition is further proof that it has something in the works in Nolita. Michael Vinocur’s firm bought the ...

We’re just days away from a new “Star Wars” movie hitting theaters.. But if you’ve seen any of the purposefully vague trailers for “The Mandalorian and Grogu” (in theaters May 22), they will tell you ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Man United are reportedly hoping to take advantage of the chaos at Real Madrid and sign midfielder Federico Valverde. The 27-year-old sustained a head injury and was forced to leave Real Madrid’s ...

GPT-Realtime-2 brings GPT-5-class reasoning to live voice. A separate translation model covers 70+ input languages. A streaming Whisper variant handles transcription. The pricing is aggressive enough ...

The Florida Python Challenge brings out a fascinating cast of characters, all captured by the director Xander Robin’s camera. By Alissa Wilkinson When you purchase a ticket for an independently ...

OpenAI’s latest voice AI model, GPT Realtime 2, introduces advanced capabilities for natural and context-aware interactions. Built on the GPT-5-level reasoning framework, it handles complex tasks such ...

OpenAI said Thursday that its API will now include a number of new voice intelligence features designed to help developers create apps that can talk, transcribe, and translate conversations with users ...

Real Madrid’s midfield is clearly in desperate need of a massive overhaul, and it looks like club president Florentino Perez has finally locked onto his primary target. Following another deeply ...

WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the ‌agency to monitor clinical trial data in real time, a step the agency ...

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.